Literature DB >> 28383539

Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System.

E Gomez-Pomar1, A Christian2, L Devlin3, K T Ibonia1, V A Concina1, H Bada1, P M Westgate4.   

Abstract

OBJECTIVE: To evaluate factors that can influence the Finnegan Neonatal Abstinence Score (FNAS). STUDY
DESIGN: Retrospective analysis of 367 patients admitted to two level IV neonatal intensive care units. Linear mixed effects models were developed to evaluate daily census, time of the day, and day of the week as fixed effect predictors. The degree of influence that nurses had on FNAS variability was also estimated.
RESULTS: Bivariate analyses showed that daily census and the time of day have significant influence on the FNAS in institution 1, with minimal clinical significance. The proportion of variation in the FNAS attributable to differences in nurses was of 9.8% and 5.1% for institutions 1 and 2, respectively (P<0.0001).
CONCLUSIONS: The minimal influences of extraneous factors on the FNAS support the clinical utility of the scoring system in the assessment and management of infants with Neonatal Abstinence Score.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28383539     DOI: 10.1038/jp.2017.40

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  17 in total

1.  Assessment and treatment of abstinence in the infant of the drug-dependent mother.

Authors:  L P Finnegan; R E Kron; J F Connaughton; J P Emich
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

2.  Neonatal abstinence syndrome: assessment and management.

Authors:  L P Finnegan; J F Connaughton; R E Kron; J P Emich
Journal:  Addict Dis       Date:  1975

3.  Implementing practice guidelines and education to improve care of infants with neonatal abstinence syndrome.

Authors:  Katherine Lucas; Robin B Knobel
Journal:  Adv Neonatal Care       Date:  2012-02       Impact factor: 1.968

4.  Neonatal opioid withdrawal and antenatal opioid prescribing.

Authors:  Suzanne D Turner; Tara Gomes; Ximena Camacho; Zhan Yao; Astrid Guttmann; Muhammad M Mamdani; David N Juurlink; Irfan A Dhalla
Journal:  CMAJ Open       Date:  2015-01-13

Review 5.  Drug-exposed neonates.

Authors:  G Hoegerman; C A Wilson; E Thurmond; S H Schnoll
Journal:  West J Med       Date:  1990-05

6.  Neonatal Abstinence Syndrome: Presentation and Treatment Considerations.

Authors:  Hendrée E Jones; Karol Kaltenbach; Elisabeth Johnson; Carl Seashore; Emily Freeman; Erin Malloy
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

7.  An overview of clinical tools used to assess neonatal abstinence syndrome.

Authors:  Susan Orlando
Journal:  J Perinat Neonatal Nurs       Date:  2014 Jul-Sep       Impact factor: 1.638

8.  Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants.

Authors:  Urs Zimmermann-Baer; Ursula Nötzli; Katharina Rentsch; Hans Ulrich Bucher
Journal:  Addiction       Date:  2010-03       Impact factor: 6.526

9.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

10.  Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.

Authors:  Rishi J Desai; Krista F Huybrechts; Sonia Hernandez-Diaz; Helen Mogun; Elisabetta Patorno; Karol Kaltenbach; Leslie S Kerzner; Brian T Bateman
Journal:  BMJ       Date:  2015-05-14
View more
  5 in total

Review 1.  Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities.

Authors:  Elisabeth Conradt; Tess Flannery; Judy L Aschner; Robert D Annett; Lisa A Croen; Cristiane S Duarte; Alexander M Friedman; Constance Guille; Monique M Hedderson; Julie A Hofheimer; Miranda R Jones; Christine Ladd-Acosta; Monica McGrath; Angela Moreland; Jenae M Neiderhiser; Ruby H N Nguyen; Jonathan Posner; Judith L Ross; David A Savitz; Steven J Ondersma; Barry M Lester
Journal:  Pediatrics       Date:  2019-09       Impact factor: 9.703

Review 2.  The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management.

Authors:  Enrique Gomez-Pomar; Loretta P Finnegan
Journal:  Front Pediatr       Date:  2018-02-22       Impact factor: 3.418

3.  Development of an abbreviated symptom score for the neonatal abstinence syndrome.

Authors:  I Chervoneva; S C Adeniyi-Jones; F Blanco; W K Kraft
Journal:  J Perinatol       Date:  2020-02-19       Impact factor: 2.521

4.  Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.

Authors:  Enrique Gomez Pomar; Loretta P Finnegan; Lori Devlin; Henrietta Bada; Vanessa A Concina; Katrina T Ibonia; Philip M Westgate
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

Review 5.  Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics.

Authors:  Philip M Westgate; Enrique Gomez-Pomar
Journal:  Front Pediatr       Date:  2017-09-20       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.